The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
New insights into TGF-β/Smad signaling in tissue fibrosis
Open accessAbstract
Transforming growth factor-β1 (TGF-β1) is considered as a crucial mediator in tissue fibrosis and causes tissue scarring largely by activating its downstream small mother against decapentaplegic (Smad) signaling. Different TGF-β signalings play different roles in fibrogenesis. TGF-β1 directly activates Smad signaling which triggers pro-fibrotic gene overexpression. Excessive studies have demonstrated that dysregulation of TGF-β1/Smad pathway was an important pathogenic mechanism in tissue fibrosis. Smad2 and Smad3 are the two major downstream regulator that promote TGF-β1-mediated tissue fibrosis, while Smad7 serves as a negative feedback regulator of TGF-β1/Smad pathway thereby protects against TGF-β1-mediated fibrosis. This review presents an overview of the molecular mechanisms of TGF-β/Smad signaling pathway in renal, hepatic, pulmonary and cardiac fibrosis, followed by an in-depth discussion of their molecular mechanisms of intervention effects both in vitro and in vivo. The role of TGF-β/Smad signaling pathway in tumor or cancer is also discussed. Additionally, the current advances also highlight targeting TGF-β/Smad signaling pathway for the prevention of tissue fibrosis. The review reveals comprehensive pathophysiological mechanisms of tissue fibrosis. Particular challenges are presented and placed within the context of future applications against tissue fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056
TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology
Morikawa, M., Derynck, R., & Miyazono, K. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021873 · Cited by 1,321
Biernacka, A., Dobaczewski, M., & Frangogiannis, N. G. (2011) · Growth Factors · doi:10.3109/08977194.2011.595714 · Cited by 1,161
Roberts, A. B., Anzano, M. A., Lamb, L. C., Smith, J. M., & Sporn, M. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5339 · Cited by 919
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Signaling Receptors for TGF-β Family Members
Heldin, C.-H., & Moustakas, A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022053 · Cited by 711
Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis
Liu, R.-M., & Desai, L. P. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.009 · Cited by 702
Non-Smad Signaling Pathways of the TGF-β Family
Zhang, Y. E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022129 · Cited by 697
Inflammatory processes in renal fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.114 · Cited by 690
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
Margadant, C., & Sonnenberg, A. (2010) · The EMBO Reports · doi:10.1038/embor.2009.276 · Cited by 653
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
The role of TGF-β/SMAD4 signaling in cancer
Zhao, M., Mishra, L., & Deng, C.-X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23230 · Cited by 631 · cited 1×
“Smad2 phosphorylation and increased Smad2 auto-inhibition influence protein stability and suppress tumor [67,68].”
BackgroundSmad2 role in mesoderm formation, left–right patterning and craniofacial development
Nomura, M., & Li, E. (1998) · Nature · doi:10.1038/31693 · Cited by 599
Xu, Y., Mizuno, T., Sridharan, A., Du, Y., Guo, M., Tang, J., Wikenheiser-Brokamp, K. A., Perl, A.-K. T., Funari, V. A., Gokey, J. J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90558 · Cited by 580
Mu, Y., Gudey, S. K., & Landström, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1201-y · Cited by 545
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Walton, K. L., Johnson, K. E., & Harrison, C. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00461 · Cited by 543
Sirard, C., de la Pompa, J. L., Elia, A., Itie, A., Mirtsos, C., Cheung, A., Hahn, S., Wakeham, A., Schwartz, L., Kern, S. E., et al. (1998) · Genes & Development · doi:10.1101/gad.12.1.107 · Cited by 502
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
Structural determinants of Smad function in TGF-β signaling
Macias, M. J., Martin-Malpartida, P., & Massagué, J. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.03.012 · Cited by 372
Chen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
Self-citationTranscriptional Control by the SMADs
Hill, C. S. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022079 · Cited by 351
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Hernández-Aquino, E., & Muriel, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i16.1679 · Cited by 347
The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis
Sun, Y. B. Y., Qu, X., Caruana, G., & Li, J. (2016) · Differentiation · doi:10.1016/j.diff.2016.05.008 · Cited by 341
Chemical Constituents and Pharmacological Properties ofPoria cocos
Rı́os, J.-L. (2011) · Planta Medica · doi:10.1055/s-0030-1270823 · Cited by 314
TGF-β 1/Smads and miR-21 in Renal Fibrosis and Inflammation
Loboda, A., Sobczak, M., Jozkowicz, A., & Dulak, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/8319283 · Cited by 297
The TAK1–TRAF6 signalling pathway
Landström, M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.023 · Cited by 280
TGF-β signaling in the kidney: profibrotic and protective effects
Sureshbabu, A., Muhsin, S. A., & Choi, M. E. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00365.2015 · Cited by 267
Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer
Jung, B., Staudacher, J. J., & Beauchamp, D. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.015 · Cited by 241
Yue, Y., Meng, K., Pu, Y., & Zhang, X. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.018 · Cited by 240
Metabolomics in chronic kidney disease
Zhao, Y.-Y. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.03.033 · Cited by 216
Self-citationLi, M., Krishnaveni, M. S., Li, C., Zhou, B., Xing, Y., Banfalvi, A., Li, A., Lombardi, V., Akbari, O., Borok, Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42090 · Cited by 213
Wang, M., Chen, L., Liu, D., Chen, H., Tang, D.-D., & Zhao, Y.-Y. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.011 · Cited by 207
Self-citationTGF-β family co-receptor function and signaling
Nickel, J., Ten Dijke, P., & Mueller, T. D. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx126 · Cited by 198
Post‐translational regulation of TGF‐β receptor and Smad signaling
Xu, P., Liu, J., & Derynck, R. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.010 · Cited by 198
Meng, X.-M., Huang, X. R., Xiao, J., Chung, A. C. K., Qin, W., Chen, H.-Y., & Lan, H. Y. (2012) · Kidney International · doi:10.1038/ki.2011.327 · Cited by 179
Zhao, Y.-Y., Wang, H.-L., Cheng, X.-L., Wei, F., Bai, X., Lin, R.-C., & Vaziri, N. D. (2015) · Scientific Reports · doi:10.1038/srep12936 · Cited by 173
Self-citationTGF-β1/p53 signaling in renal fibrogenesis
Higgins, S. P., Tang, Y., Higgins, C. E., Mian, B. M., Zhang, W., Czekay, R., Samarakoon, R., Conti, D. J., & Higgins, P. J. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.11.005 · Cited by 163
Wang, M., Chen, D., Chen, L., Cao, G., Zhao, H., Liu, D., Vaziri, N. D., Guo, Y., & Zhao, Y. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14333 · Cited by 163
Self-citationChen, H., Cao, G., Chen, D.-Q., Wang, M., Vaziri, N. D., Zhang, Z.-H., Mao, J.-R., Bai, X., & Zhao, Y.-Y. (2016) · Redox Biology · doi:10.1016/j.redox.2016.09.014 · Cited by 162
Self-citationTian, T., Chen, H., & Zhao, Y.-Y. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.061 · Cited by 161
Self-citationTransforming growth factor β and severe asthma: A perfect storm
Al‐Alawi, M., Hassan, T. M., & Chotirmall, S. H. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.08.008 · Cited by 161
Chen, D.-Q., Cao, G., Chen, H., Liu, D., Su, W., Yu, X.-Y., Vaziri, N. D., Liu, X.-H., Bai, X., Zhang, L., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.017 · Cited by 161
Self-citationWang, Y., Zhang, J., Zhao, Y., Li, T., Shen, T., Li, J., Li, W., & Liu, H. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.03.027 · Cited by 159
Self-citationZhang, Z., Wei, F., Vaziri, N. D., Cheng, X., Bai, X., Lin, R., & Zhao, Y. (2015) · Scientific Reports · doi:10.1038/srep14472 · Cited by 159
Self-citationTransforming growth factor‐β/ S mad signalling in diabetic nephropathy
Lan, H. Y. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05663.x · Cited by 156
TGF-β signaling in liver and gastrointestinal cancers
Katz, L. H., Likhter, M., Jogunoori, W. S., Belkin, M. D., Ohshiro, K., & Mishra, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.033 · Cited by 148
Verrecchia, F., & Rédiní, F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00133 · Cited by 144
Traditional uses, fermentation, phytochemistry and pharmacology of Phellinus linteus: A review
Chen, H., Tian, T., Miao, H., et al. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.06.009 · Cited by 141
Zhang, Z., Vaziri, N. D., Wei, F., Cheng, X., Bai, X., & Zhao, Y. (2016) · Scientific Reports · doi:10.1038/srep22151 · Cited by 137
Self-citationZhao, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.06.031 · Cited by 127
Self-citationWang, M., Chen, D., Chen, L., Liu, D., Zhao, H., Zhang, Z., Vaziri, N. D., Guo, Y. P., Zhao, Y., & Cao, G. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00099 · Cited by 126
Self-citationTGFβ pathway inhibition in the treatment of non-small cell lung cancer
Eser, P. Ö., & Janne, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.004 · Cited by 121
Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B
Liu, P. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i4.679 · Cited by 118
Targeting podocyte-associated diseases☆
Leeuwis, J. W., Nguyen, T. Q., Dendooven, A., Kok, R. J., & Goldschmeding, R. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.012 · Cited by 113
Structural Basis of Intracellular TGF-β Signaling: Receptors and SmadsPreprint
Chaikuad, A., & Bullock, A. N. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022111 · Cited by 108
Zhao, Y., Vaziri, N. D., & Lin, R. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2014.11.002 · Cited by 107
Self-citationLipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with Poria cocos
Miao, H., Zhao, Y., Vaziri, N. D., Tang, D., Chen, H., Chen, H., Khazaeli, M., Boldaji, M. T., Hatami, L., & Zhao, Y. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05350 · Cited by 106
Self-citationRole of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary Fibrosis
Kang, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122527 · Cited by 106
Zhao, Y., Li, H., Feng, Y., Bai, X., & Lin, R. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.04.018 · Cited by 103
Self-citationTGF-β1 Evokes Human Airway Smooth Muscle Cell Shortening and Hyperresponsiveness via Smad3
Ojiaku, C. A., Cao, G., Zhu, W., Yoo, E., Shumyatcher, M., Himes, B. E., An, S. S., & Panettieri, R. A. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0247oc · Cited by 102
Self-citationChen, L., Chen, D., Wang, M., Liu, D., Chen, H., Dou, F., Vaziri, N. D., & Zhao, Y. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.025 · Cited by 100
Self-citationWang, M., Chen, D., Wang, M., et al. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.10.008 · Cited by 97
Self-citationChen, H., Tian, Y., Wang, M., Chen, D., Yang, Y., & Zhao, Y.-Y. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.03.034 · Cited by 96
Self-citationZhao, Y., Cheng, X., Cui, J., Yan, X., Wei, F., Bai, X., & Lin, R. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.06.005 · Cited by 93
Self-citationWang, D., Huang, R.-H., Cheng, X., Zhang, Z.-H., Yang, Y., & Lin, X. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.027 · Cited by 88
Metabolomics in Nephrotoxicity
Zhao, Y., & Lin, R. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800141-7.00003-6 · Cited by 87
Self-citationMuñoz‐Félix, J. M., González-Núñez, M., Martínez‐Salgado, C., & López-Novoa, J. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.003 · Cited by 84
Zhao, Y., Li, Z., Long, F.-Y., Cheng, X., Bai, X., Wei, F., & Lin, R. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.12.002 · Cited by 81
Self-citationCai, H.-D., Su, S., Li, Y., Zeng, H., Zhu, Z., Guo, J., Zhu, K. Y., Guo, S., Yu, L., Qian, D., et al. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.021 · Cited by 80
Involvement of epithelial-mesenchymal transition in liver fibrosis
Li, N., Yu, K., Li, Q., & Shi, G. (2018) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_297_17 · Cited by 80
Qin, T., Yin, S., Yang, J., Zhang, Q., Liu, Y., Huang, F., & Cao, W. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.05.009 · Cited by 78
Zhang, M., Chiu, L. C. M., Cheung, P. C. K., & Ooi, V. E. C. (2006) · Oncology Reports · doi:10.3892/or.15.3.637 · Cited by 70
Liu, Z., Huang, X., Chen, H., Fung, E., Liu, J., & Lan, H.-Y. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09600 · Cited by 59
TGFβ as a therapeutic target in cystic fibrosis
Kramer, E. L., & Clancy, J. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1406922 · Cited by 59
Proteomics for Biomarker Identification and Clinical Application in Kidney Disease
Chen, L., Su, W. C., Chen, H., Chen, D., Wang, M., Guo, Y. P., & Zhao, Y. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.02.005 · Cited by 59
Self-citationSMAD7: a timer of tumor progression targeting TGF-β signaling
Luo, L., Li, N., Lv, N., & Huang, D. (2014) · Tumor Biology · doi:10.1007/s13277-014-2203-7 · Cited by 57
Dou, F., Miao, H., Wang, J., Chen, L., Wang, M., Chen, H., Wen, A., & Zhao, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00053 · Cited by 56
Self-citationÁbrigo, J., Campos, F., Simón, F., Riedel, C. A., Cabrera, D., Vilos, C., & Cabello‐Verrugio, C. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0217 · Cited by 55
Loeffler, I., Liebisch, M., Allert, S., Kunisch, E., Kinne, R. W., & Wolf, G. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2754-1 · Cited by 54
Liu, H., Dong, F., Li, G., Niu, M., Zhang, C.-E., Han, Y., He, L.-Z., Yin, P., Wang, B., Xiuxiu, S., et al. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.08.029 · Cited by 52
Vitamin D and Myofibroblasts in Fibrosis and Cancer: At Cross-purposes with TGF-β/SMAD Signaling
Shany, S., Sigal-Batikoff, I., & Lamprecht, S. A. (2016) · Anticancer Research · doi:10.21873/anticanres.11216 · Cited by 50
Li, Z. L., Shi, Y., Ding, Y., Ran, Y., & Le, G. (2016) · Amino Acids · doi:10.1007/s00726-016-2353-6 · Cited by 49
Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice
Meng, X., Mao, Z., Li, X., Zhong, D., Li, M., Jia, Y., Wei, J., Yang, B., & Zhou, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16928 · Cited by 46
You, S., Ma, L., Zhao, J., Zhang, S., & Liu, T. (2016) · Molecules · doi:10.3390/molecules21010102 · Cited by 44
Chen, H., Song, H., Liu, X., Tian, J., Tang, W., Cao, T., Zhao, P., Zhang, C., Guo, W., Xu, M. G., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.102 · Cited by 40
Zhang, Z., Mao, J., Chen, H., Su, W. C., Zhang, Y., Zhang, L., Chen, D., Zhao, Y., & Vaziri, N. D. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.09.012 · Cited by 40
Self-citationUrinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia
Miao, H., Li, Z., Chen, D., Chen, H., Zhao, Y., & Ma, S. (2016) · Biomedical Chromatography · doi:10.1002/bmc.3829 · Cited by 38
Self-citationChu, H., Shi, Y., Jiang, S., Zhong, Q., Zhao, Y., Liu, Q., Ma, Y., Shi, X., Ding, W., Zhou, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02293-z · Cited by 38
Self-citationLi, Y., Song, F., Li, H., Li, Y., Li, J., He, Q., Zhang, D., Wang, F., Zhang, M., Zhao, H., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.145 · Cited by 37
Self-citationOuyang, Y., Miyata, M., Hatsushika, K., Ohnuma, Y., Katoh, R., Ogawa, H., Okumura, K., Masuyama, K., & Nakao, A. (2010) · Allergology International · doi:10.2332/allergolint.10-sc-0172 · Cited by 36
Anti-fibrotic effect of wogonin in renal tubular epithelial cells via Smad3-dependent mechanisms
Meng, X., Ren, G., Gao, L., Li, H.-D., Wu, W., Li, X., Xu, T., Wang, X.-F., Ma, T., Li, Z., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.07.014 · Cited by 36
Role of SMAD proteins in colitis-associated cancer: from known to the unknown
Chandrasinghe, P. C., Cereser, B., Moorghen, M., Bakir, I. A., Tabassum, N., Hart, A., Stebbing, J., & Warusavitarne, J. H. (2017) · Oncogene · doi:10.1038/onc.2017.300 · Cited by 35
Yang, J., Kan, M., & Wu, G. Y. (2016) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2016.1142560 · Cited by 28
Wang, L., Cao, A.-L., Chi, Y.-F., Ju, Z., Yin, P., Zhang, X., & Peng, W. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.04.037 · Cited by 27
Protective Role of Oryeongsan Against Renal Inflammation and Glomerulosclerosis in db/db Mice
Yoon, J. J., Lee, Y. J., Kang, D. G., & Lee, H. S. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500906 · Cited by 21
Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline
Harris, W. T., Boyd, J. T., McPhail, G. L., Brody, A. S., Szczesniak, R. D., Korbee, L. L., Baker, M. L., & Clancy, J. P. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-594oc · Cited by 14
Cited by
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
Self-citationEnergy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Antar, S. A., Ashour, N. A., Marawan, M. E., & Al-Karmalawy, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044004 · Cited by 366
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Hammouda, M., Ford, A., Liu, Y., & Zhang, J. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 284
Metadata
- Authors
- Hu, H.-H., Chen, D.-Q., Wang, Y.-N., Feng, Y.-L., Cao, G., Vaziri, N. D., & Zhao, Y.-Y.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 292
- Pages
- 76-83
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W2881438881
- Cited by
- 1,179
- References
- 99
- FWCI
- 23.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.